AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34217789 — intervention group
Group type: COMPARATOR
Intervention: Radical irradiation vs No irradiation
Number of subjects: 102
Study 34217789 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical vs Partial irradiation
Number of subjects: 102
Study 33023513 — intervention group
Group type: EXPERIMENTAL
Intervention: 14‐h Youth MHFA course
Number of subjects: 384
Study 33023513 — intervention group
Group type: COMPARATOR
Intervention: 15‐h Australian Red Cross Provide First Aid course
Number of subjects: 384
Study 36181108 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotics combined with mucosolvan perfusion therapy under fiber bronchoscope
Number of subjects: 120
Study 36181108 — intervention group
Group type: COMPARATOR
Intervention: Antibiotics combined with mucosolvan lavage therapy under fiber bronchoscope
Number of subjects: 120
Study 34225202 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated transport at -10°C
Number of subjects: 210
Study 34225202 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated transport
Number of subjects: 210
Study 34225202 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated transport for longer duration at -10°C
Number of subjects: 210
Study 33263644 — intervention group
Group type: EXPERIMENTAL
Intervention: Oseltamivir (75 mg orally twice daily for 5 days)
Number of subjects: 160
Study 33263644 — intervention group
Group type: COMPARATOR
Intervention: Zanamivir (10 mg inhaled twice daily for 5 days)
Number of subjects: 160
Study 34076770 — intervention group
Group type: EXPERIMENTAL
Intervention: Inside-stent therapy
Number of subjects: 43
Study 34076770 — intervention group
Group type: COMPARATOR
Intervention: Conventional-stent therapy
Number of subjects: 43
Study 34076770 — intervention group
Group type: EXPERIMENTAL
Intervention: Inside-stent therapy as second stent
Number of subjects: 43
Study 34076770 — intervention group
Group type: EXPERIMENTAL
Intervention: Technical and clinical success rate
Number of subjects: 43
Study 34076770 — intervention group
Group type: EXPERIMENTAL
Intervention: Re-intervention rate
Number of subjects: 43
Study 34076770 — intervention group
Group type: EXPERIMENTAL
Intervention: Second stent patency
Number of subjects: 43
Study 34076770 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 43
Study 34076770 — intervention group
Group type: EXPERIMENTAL
Intervention: Survival probability
Number of subjects: 43
Study 34473781 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronological age standardization
Number of subjects: 554
Study 34473781 — intervention group
Group type: COMPARATOR
Intervention: Corrected age standardization
Number of subjects: 554
Study 36102002 — intervention group
Group type: EXPERIMENTAL
Intervention: Centrifugation (30 min daily)
Number of subjects: 19
Study 36102002 — intervention group
Group type: COMPARATOR
Intervention: Bed rest (55 days)
Number of subjects: 19
Study 35227041 — intervention group
Group type: EXPERIMENTAL
Intervention: Adper Single Bond 2
Number of subjects: 108
Study 35227041 — intervention group
Group type: EXPERIMENTAL
Intervention: G-premio Bond
Number of subjects: 108
Study 35227041 — intervention group
Group type: EXPERIMENTAL
Intervention: Single Bond Universal
Number of subjects: 108
Study 35227041 — intervention group
Group type: COMPARATOR
Intervention: C-factor
Number of subjects: 108
Study 35227041 — intervention group
Group type: EXPERIMENTAL
Intervention: Adper Single Bond 2 vs flat wall and flat floor
Number of subjects: 108
Study 35227041 — intervention group
Group type: EXPERIMENTAL
Intervention: Cavity wall and cavity floor
Number of subjects: 108
Study 32187772 — intervention group
Group type: EXPERIMENTAL
Intervention: MTAD + PIPS
Number of subjects: 55
Study 32187772 — intervention group
Group type: EXPERIMENTAL
Intervention: PIPS
Number of subjects: 55
Study 32187772 — intervention group
Group type: EXPERIMENTAL
Intervention: MTAD
Number of subjects: 55
Study 32187772 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5% NaOCl + 17% EDTA
Number of subjects: 55
Study 32187772 — intervention group
Group type: COMPARATOR
Intervention: Distilled water (control)
Number of subjects: 55
Study 34206160 — intervention group
Group type: EXPERIMENTAL
Intervention: iodine‐reduced kelp powder (6 g kelp powder corresponding to 3 g alginate/d)
Number of subjects: 50
Study 34206160 — intervention group
Group type: COMPARATOR
Intervention: kelp‐free powder (placebo)
Number of subjects: 50
Study 32291210 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term persistent negative symptoms (PNS)
Number of subjects: 100
Study 32291210 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine treatment (phase 3)
Number of subjects: 100
Study 32291210 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative symptoms (moderate severity)
Number of subjects: 100
Study 32291210 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-week treatment
Number of subjects: 100
Study 32500827 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-strain probiotic supplementation (2 capsules daily for six months)
Number of subjects: 70
Study 33038501 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 250
Study 33038501 — intervention group
Group type: COMPARATOR
Intervention: Education/support control
Number of subjects: 250
Study 33530822 — intervention group
Group type: EXPERIMENTAL
Intervention: Relocation of intravenous pumps from bedside to outside the patient room using extension tubing
Number of subjects: 0
Study 33530822 — intervention group
Group type: COMPARATOR
Intervention: Pre-pump relocation
Number of subjects: 0
Study 33530822 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-pump relocation
Number of subjects: 0
Study 34752941 — intervention group
Group type: EXPERIMENTAL
Intervention: Two ketamine infusions (n=30; days 1 and 4)
Number of subjects: 78
Study 34752941 — intervention group
Group type: EXPERIMENTAL
Intervention: Single ketamine infusion (n=24; only day 1)
Number of subjects: 78
Study 34752941 — intervention group
Group type: COMPARATOR
Intervention: Normal saline placebo infusion (n=24; only day 1)
Number of subjects: 78
Study 32416376 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 Gy in 5 fractions delivered every other day (EOD)
Number of subjects: 152
Study 32416376 — intervention group
Group type: COMPARATOR
Intervention: 40 Gy in 5 fractions delivered once per week (QW)
Number of subjects: 152
Study 34531554 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrapolyp triamcinolone acetonide (TA) injection (20 mg/ml, 2 mL)
Number of subjects: 43
Study 34531554 — intervention group
Group type: COMPARATOR
Intervention: Placebo normal saline injection (2 mL)
Number of subjects: 43
Study 32473928 — intervention group
Group type: EXPERIMENTAL
Intervention: LCD+INT (60 min/d of supervised interval exercise at 90% HRpeak for 3 min and 50% HRpeak for 3 min)
Number of subjects: 26
Study 32473928 — intervention group
Group type: COMPARATOR
Intervention: LCD (mixed meals of 1200 kcal/d)
Number of subjects: 26
Study 32473928 — intervention group
Group type: EXPERIMENTAL
Intervention: LCD+INT
Number of subjects: 26
Study 32473928 — intervention group
Group type: COMPARATOR
Intervention: LCD
Number of subjects: 26
Study 34787917 — intervention group
Group type: EXPERIMENTAL
Intervention: PFMT + MVT
Number of subjects: 52
Study 34787917 — intervention group
Group type: COMPARATOR
Intervention: PFMT + MST
Number of subjects: 52
Study 34397879 — intervention group
Group type: EXPERIMENTAL
Intervention: Rational-emotive psychotherapy
Number of subjects: 568
Study 34397879 — intervention group
Group type: COMPARATOR
Intervention: Waitlist group (Control)
Number of subjects: 568
Study 32488332 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabeprazole 10 mg qd
Number of subjects: 12
Study 32488332 — intervention group
Group type: EXPERIMENTAL
Intervention: Rabeprazole 5 mg bid
Number of subjects: 12
Study 32488332 — intervention group
Group type: COMPARATOR
Intervention: Rabeprazole 5 mg qd
Number of subjects: 12
Study 34487181 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise intervention (n = 36)
Number of subjects: 54
Study 34487181 — intervention group
Group type: COMPARATOR
Intervention: Wait-list usual care (n = 18)
Number of subjects: 54
Study 35436950 — intervention group
Group type: EXPERIMENTAL
Intervention: LPG cookstove and LPG in cylinders supplied throughout pregnancy until birth
Number of subjects: 4944
Study 35436950 — intervention group
Group type: COMPARATOR
Intervention: Usual cooking practices (traditional stoves with biomass fuel)
Number of subjects: 4944
Study 35436950 — intervention group
Group type: EXPERIMENTAL
Intervention: LPG cookstove
Number of subjects: 4944
Study 34341409 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrauterine antibiotic infusion (IAI) combined with oral antibiotic administration (OAA)
Number of subjects: 80
Study 34341409 — intervention group
Group type: COMPARATOR
Intervention: Oral antibiotic administration (OAA)
Number of subjects: 80
Study 34341409 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrauterine antibiotic infusion (IAI)
Number of subjects: 80
Study 32636011 — intervention group
Group type: EXPERIMENTAL
Intervention: CDH
Number of subjects: 36
Study 32636011 — intervention group
Group type: COMPARATOR
Intervention: ICE
Number of subjects: 36
Study 32636011 — intervention group
Group type: COMPARATOR
Intervention: NON
Number of subjects: 36
Study 33547265 — intervention group
Group type: EXPERIMENTAL
Intervention: Velocity-based strength training with a 10% velocity loss (VL10)
Number of subjects: 21
Study 33547265 — intervention group
Group type: COMPARATOR
Intervention: Traditional 1‐repetition maximum (1RM) based resistance training to failure (TRF)
Number of subjects: 21
Study 33547265 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 21
Study 33380479 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-task exercise programme with caregiver participation
Number of subjects: 300
Study 33380479 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-task exercise programme without caregiver participation
Number of subjects: 300
Study 33380479 — intervention group
Group type: COMPARATOR
Intervention: Aerobic-balance-stretching exercise programme (control group)
Number of subjects: 300
Study 33909348 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 802
Study 33909348 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated Heparin (UFH)
Number of subjects: 802
Study 33909348 — intervention group
Group type: EXPERIMENTAL
Intervention: Anemic patients
Number of subjects: 802
Study 32702468 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorpropamide–glibenclamide–basal insulin
Number of subjects: 2339
Study 32702468 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 2339
Study 33940549 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A: Left superior GP (LSGP) ‐ Left inferior GP (LIGP) ‐ Right inferior GP (RIGP) ‐ Right anterior GP (RAGP)
Number of subjects: 28
Study 33940549 — intervention group
Group type: COMPARATOR
Intervention: Group B: RAGP ‐ LSGP ‐ LIGP ‐ RIGP
Number of subjects: 28
Study 33940549 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups during ablation of RAGP
Number of subjects: 28
Study 33248587 — intervention group
Group type: EXPERIMENTAL
Intervention: PAD63d
Number of subjects: 360
Study 33248587 — intervention group
Group type: EXPERIMENTAL
Intervention: PAD77d
Number of subjects: 360
Study 33248587 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 360
Study 35833450 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative Medicine consultation within 24 hours
Number of subjects: 91
Study 35833450 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-care
Number of subjects: 91
Study 33387333 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine infusions
Number of subjects: 127
Study 32781360 — intervention group
Group type: EXPERIMENTAL
Intervention: PBMC-therapy (intrauterine administration of autologous hCG-activated PBMCs)
Number of subjects: 100
Study 32781360 — intervention group
Group type: COMPARATOR
Intervention: Control group (PBS-injecting)
Number of subjects: 100
Study 34162719 — intervention group
Group type: EXPERIMENTAL
Intervention: Poultry farming
Number of subjects: 427
Study 34162719 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrazine use
Number of subjects: 427
Study 34162719 — intervention group
Group type: COMPARATOR
Intervention: Villagers
Number of subjects: 427
Study 35349378 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone contraceptives
Number of subjects: 0
Study 35349378 — intervention group
Group type: COMPARATOR
Intervention: Naturally cycling women
Number of subjects: 0
Study 34016410 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranger drug‐coated balloon (DCB) (paclitaxel dose density 2 μg/mm2)
Number of subjects: 376
Study 34016410 — intervention group
Group type: COMPARATOR
Intervention: Standard percutaneous transluminal angioplasty (PTA)
Number of subjects: 376
Study 34016410 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranger drug‐coated balloon (DCB)
Number of subjects: 376
Study 32882390 — intervention group
Group type: EXPERIMENTAL
Intervention: Upstream administration of ticagrelor before angiography
Number of subjects: 1449
Study 32882390 — intervention group
Group type: COMPARATOR
Intervention: Downstream administration of ticagrelor or prasugrel after angiography
Number of subjects: 1449
Study 35091845 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-led pharmaceutical care program
Number of subjects: 115
Study 35091845 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 115
Study 33407845 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide/oxygen mixture
Number of subjects: 42
Study 33407845 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment plus oxygen (Control)
Number of subjects: 42
Study 34344494 — intervention group
Group type: EXPERIMENTAL
Intervention: Edoxaban
Number of subjects: 150
Study 34344494 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (vitamin K antagonist and low molecular weight heparin)
Number of subjects: 150
Study 34283841 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron-containing micronutrient powder (12.5 mg of iron daily)
Number of subjects: 871
Study 34283841 — intervention group
Group type: COMPARATOR
Intervention: Placebo (micronutrient powder without iron)
Number of subjects: 871
Study 34283841 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron-containing micronutrient powder (among iron-sufficient or iron-replete children)
Number of subjects: 871
Study 34283841 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with sufficient iron status
Number of subjects: 871
Study 32193740 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with Type 2 Diabetes Mellitus (T2DM)
Number of subjects: 188
Study 32193740 — intervention group
Group type: COMPARATOR
Intervention: Patients without Type 2 Diabetes Mellitus (non-T2DM)
Number of subjects: 188
Study 32193740 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with Type 2 Diabetes Mellitus (T2DM) with pathologic acid reflux
Number of subjects: 188
Study 34174859 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous curved kyphoplasty (PCKP)
Number of subjects: 72
Study 34174859 — intervention group
Group type: COMPARATOR
Intervention: Bilateral percutaneous kyphoplasty (PKP)
Number of subjects: 72
Study 34174859 — intervention group
Group type: EXPERIMENTAL
Intervention: Both PCKP and PKP
Number of subjects: 72
Study 33162797 — intervention group
Group type: EXPERIMENTAL
Intervention: FFP3 filtering respirators
Number of subjects: 78
Study 33162797 — intervention group
Group type: COMPARATOR
Intervention: Surgical masks
Number of subjects: 78
Study 35537786 — intervention group
Group type: EXPERIMENTAL
Intervention: Regimen-DI (doxorubicin 6×75 mg/m2/week; cisplatin 6×100 mg/m2/week every 2 weeks)
Number of subjects: 497
Study 35537786 — intervention group
Group type: COMPARATOR
Intervention: Regimen-C (doxorubicin 6×75 mg/m2/week; cisplatin 6×100 mg/m2/week every 3 weeks)
Number of subjects: 497
Study 35537786 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified regimen (compared to control)
Number of subjects: 497
Study 35537786 — intervention group
Group type: EXPERIMENTAL
Intervention: Histological response
Number of subjects: 497
Study 32843424 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate calorie restriction
Number of subjects: 0
Study 34075630 — intervention group
Group type: EXPERIMENTAL
Intervention: onabotulinumtoxinA 200 units
Number of subjects: 21
Study 34075630 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 21
Study 34075630 — intervention group
Group type: EXPERIMENTAL
Intervention: onabotulinumtoxinA
Number of subjects: 21
Study 33726637 — intervention group
Group type: EXPERIMENTAL
Intervention: Senior Mentor Program (SMP)
Number of subjects: 102
Study 34475094 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative serum levels of carcinoembryonic antigen (CEA)
Number of subjects: 120
Study 34475094 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative serum levels of cyclin‐dependent kinase regulatory subunit 2 (CKS2)
Number of subjects: 120
Study 34475094 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative serum levels of 2'‐5'‐oligoadenylate synthetase 2 (OAS2)
Number of subjects: 120
Study 34475094 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative serum levels of autophagy‐related gene 5 (ATG5)
Number of subjects: 120
Study 34475094 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of serum CEA, CKS2, OAS2, and ATG5
Number of subjects: 120
Study 34475094 — intervention group
Group type: EXPERIMENTAL
Intervention: ROC analysis of biomarkers
Number of subjects: 120
Study 35381765 — intervention group
Group type: EXPERIMENTAL
Intervention: Albumin adjusted ischemia-modified albumin (AdjIMA)
Number of subjects: 40
Study 35381765 — intervention group
Group type: EXPERIMENTAL
Intervention: Total antioxidant status (TAS)
Number of subjects: 40
Study 35381765 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemia modified albumin (IMA)
Number of subjects: 40
Study 35381765 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass index (BMI)
Number of subjects: 40
Study 35381765 — intervention group
Group type: EXPERIMENTAL
Intervention: Waist-hip ratio (WHR)
Number of subjects: 40
Study 35381765 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood pressure (BP) parameters
Number of subjects: 40
Study 33355484 — intervention group
Group type: EXPERIMENTAL
Intervention: GP-Lis25
Number of subjects: 210
Study 33355484 — intervention group
Group type: COMPARATOR
Intervention: Ly-Lis25 (Humalog Mix 25)
Number of subjects: 210
Study 35570477 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry needling (DN)
Number of subjects: 54
Study 35570477 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry needling with needle retention
Number of subjects: 54
Study 35570477 — intervention group
Group type: COMPARATOR
Intervention: Control group (not applicable)
Number of subjects: 54
Study 32856406 — intervention group
Group type: COMPARATOR
Intervention: Nurses with less clinical experience
Number of subjects: 1113
Study 32856406 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurses with more clinical experience
Number of subjects: 1113
Study 32856406 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurses with varying clinical experience
Number of subjects: 1113
Study 32856406 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurses with more experience
Number of subjects: 1113
Study 32856406 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurses' perceptions of the need for specific skills
Number of subjects: 1113
Study 35843124 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIT
Number of subjects: 23
Study 35843124 — intervention group
Group type: COMPARATOR
Intervention: MICT
Number of subjects: 23
Study 35843124 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined HIIT and MICT
Number of subjects: 23
Study 32469454 — intervention group
Group type: EXPERIMENTAL
Intervention: PCIT-ED (Parent-Child Interaction Therapy Emotion Development)
Number of subjects: 229
Study 32469454 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 229
Study 36384543 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple sutures with 4-0 vicryl threads
Number of subjects: 32
Study 36384543 — intervention group
Group type: COMPARATOR
Intervention: Cross-mattress sutures with 4-0 vicryl threads
Number of subjects: 32
Study 32068928 — intervention group
Group type: EXPERIMENTAL
Intervention: Fetal Endoscopic Tracheal Occlusion (FETO)
Number of subjects: 50
Study 32068928 — intervention group
Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 50
Study 35510723 — intervention group
Group type: EXPERIMENTAL
Intervention: Tablet personal computer distraction (animated video played during IV placement)
Number of subjects: 22
Study 35510723 — intervention group
Group type: COMPARATOR
Intervention: Control group (no tablet distraction)
Number of subjects: 22
Study 33780086 — intervention group
Group type: EXPERIMENTAL
Intervention: Paced Auditory Serial Addition Test (PASAT; cognitive effort; n=32)
Number of subjects: 38
Study 33780086 — intervention group
Group type: COMPARATOR
Intervention: Resting state (n=33)
Number of subjects: 38
Study 33780086 — intervention group
Group type: EXPERIMENTAL
Intervention: Paced Auditory Serial Addition Test (PASAT) under time pressure (n=29)
Number of subjects: 38
Study 33780086 — intervention group
Group type: EXPERIMENTAL
Intervention: Paced Auditory Serial Addition Test (PASAT) with social-evaluative threat (video camera; n=29)
Number of subjects: 38
Study 33675755 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly pegcetacoplan (15 mg)
Number of subjects: 192
Study 33675755 — intervention group
Group type: EXPERIMENTAL
Intervention: Every other month (EOM) pegcetacoplan (15 mg)
Number of subjects: 192
Study 33675755 — intervention group
Group type: COMPARATOR
Intervention: Sham injection
Number of subjects: 192
Study 32179871 — intervention group
Group type: COMPARATOR
Intervention: Congenital gastrointestinal surgical conditions (CGISCs)
Number of subjects: 37
Study 36028873 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal Facilitation (IF)
Number of subjects: 7030
Study 36028873 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal Facilitation (IF) + External Facilitation (EF)
Number of subjects: 7030
Study 33313731 — intervention group
Group type: EXPERIMENTAL
Intervention: SBIRT-PM
Number of subjects: 1100
Study 33313731 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1100
Study 32620300 — intervention group
Group type: EXPERIMENTAL
Intervention: Using the Patient Concerns Inventory (PCI) package in clinic
Number of subjects: 67
Study 32620300 — intervention group
Group type: COMPARATOR
Intervention: Not using the Patient Concerns Inventory (PCI) package in clinic
Number of subjects: 67